info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Small Molecule Drug Discovery Market Research Report Information By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) โ€“Market Forecast Till 2032


ID: MRFR/HC/20284-HCR | 128 Pages | Author: Rahul Gotadki| November 2024

Small Molecule Drug Discovery Therapeutic Market Segmentation


Small Molecule Drug Discovery Therapeutic Area Outlook (USD Billion, 2019-2032)




  • Oncology




  • Central Nervous System




  • Cardiovascular




  • Respiratory




  • Metabolic Disorders




  • Gastrointestinal




  • Other Therapeutic Areas




Small Molecule Drug Discovery Process/Phase Outlook (USD Billion, 2019-2032)




  • Target ID/Validation




  • Hit Generation and Selection




  • Lead Identification




  • Lead Optimization




Small Molecule Drug Discovery Regional Outlook (USD Billion, 2019-2032)




  • North America Outlook (USD Billion, 2019-2032)




    • North America Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • North America Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • US Outlook (USD Billion, 2019-2032)




    • US Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • US Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • CANADA Outlook (USD Billion, 2019-2032)




    • CANADA Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • CANADA Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization








  • Europe Outlook (USD Billion, 2019-2032)




    • Europe Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Europe Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Germany Outlook (USD Billion, 2019-2032)




    • Germany Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Germany Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • France Outlook (USD Billion, 2019-2032)




    • France Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • France Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • UK Outlook (USD Billion, 2019-2032)




    • UK Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • UK Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • ITALY Outlook (USD Billion, 2019-2032)




    • ITALY Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • ITALY Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • SPAIN Outlook (USD Billion, 2019-2032)




    • Spain Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Spain Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Rest Of Europe Outlook (USD Billion, 2019-2032)




    • Rest Of Europe Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • REST OF EUROPE Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization








  • Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Asia-Pacific Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Asia-Pacific Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • China Outlook (USD Billion, 2019-2032)




    • China Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • China Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Japan Outlook (USD Billion, 2019-2032)




    • Japan Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Japan Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • India Outlook (USD Billion, 2019-2032)




    • India Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • India Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Australia Outlook (USD Billion, 2019-2032)




    • Australia Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Australia Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Rest of Asia-Pacific Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Rest of Asia-Pacific Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization








  • Rest of the World Outlook (USD Billion, 2019-2032)




    • Rest of the World Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Rest of the World Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Middle East Outlook (USD Billion, 2019-2032)




    • Middle East Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Middle East Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Africa Outlook (USD Billion, 2019-2032)




    • Africa Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Africa Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization






    • Latin America Outlook (USD Billion, 2019-2032)




    • Latin America Small Molecule Drug Discovery by Therapeutic Area




      • Oncology




      • Central Nervous System




      • Cardiovascular




      • Respiratory




      • Metabolic Disorders




      • Gastrointestinal




      • Other Therapeutic Areas






    • Latin America Small Molecule Drug Discovery by Process/Phase




      • Target ID/Validation




      • Hit Generation and Selection




      • Lead Identification




      • Lead Optimization







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porterโ€™s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA

6.1. Overview

6.2. Oncology

6.3. Central Nervous System

6.4. Cardiovascular

6.5. Respiratory

6.6. Metabolic Disorders

6.7. Gastrointestinal

6.8. Other Therapeutic Areas

7. GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE

7.1. Overview

7.2. Target ID/Validation

7.3. Hit Generation and Selection

7.4. Lead Identification

7.5. Lead Optimization

8. GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Small Molecule Drug Discovery Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Small Molecule Drug Discovery Market,

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2023

9.8.2. Major Players R&D Expenditure. 2023

10. COMPANY PROFILES

10.1. Pfizer Inc.

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Merck & Co., Inc.

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Novartis AG

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Johnson & Johnson

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. AstraZeneca PLC

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. GlaxoSmithKline plc

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Bristol Myers Squibb Company

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Eli Lilly and Company

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. ROCHE HOLDING AG

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. AbbVie Inc.

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 7 US: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 8 US: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 9 CANADA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 10 CANADA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 3 GERMANY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 5 FRANCE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 6 FRANCE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 7 ITALY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 8 ITALY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 9 SPAIN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 10 SPAIN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 11 UK: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 12 UK: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 17 JAPAN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 18 JAPAN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 19 JAPAN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 20 CHINA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 21 INDIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 22 INDIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 23 AUSTRALIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 24 AUSTRALIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 33 AFRICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 34 AFRICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET

FIGURE 4 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY THERAPEUTIC AREA, 2023

FIGURE 5 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY PROCESS/PHASE, 2023

FIGURE 6 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023

FIGURE 7 NORTH AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 REST OF THE WORLD: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 12 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 PFIZER INC.: SWOT ANALYSIS

FIGURE 14 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 MERCK & CO., INC.: SWOT ANALYSIS

FIGURE 16 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 NOVARTIS AG: SWOT ANALYSIS

FIGURE 18 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 JOHNSON & JOHNSON: SWOT ANALYSIS

FIGURE 20 ASTRAZENECA PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 ASTRAZENECA PLC: SWOT ANALYSIS

FIGURE 22 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

FIGURE 24 BRISTOL MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 BRISTOL MYERS SQUIBB COMPANY: SWOT ANALYSIS

FIGURE 26 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 ELI LILLY AND COMPANY: SWOT ANALYSIS

FIGURE 28 ROCHE HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ROCHE HOLDING AG: SWOT ANALYSIS

FIGURE 30 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 ABBVIE INC.: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.